Clinical Trial Update: A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating ASTX030 in patients with myelodysplastic syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• ASTX030

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Myelodysplastic Syndrome (MDS) | Phase 1 | Status: RECRUITING